Cancer Detection and Liquid Biopsy
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read More
Search Results for: genetic testing
OGT Updates SureSeq NGS Portfolio
The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.
Read More
Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MoreConsortium Secures Eurostars Funding to Develop Multiomics Test for Colorectal Cancer
The aim of the consortium is to develop a blood test based on transcriptomic and epigenetic biomarkers for early detection and relapse monitoring in CRC patients.
Read MoreMyriad: NCCN Updates Professional Guidelines for Patients with Prostate Cancer
The Prolaris test from Myriad Genetics was one of only two prognostic tests for prostate cancer recommended by NCCN for the new expanded indications.
Read More